tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX
US Market
TVTX
Travere Therapeutics
RESEARCH TOOLSreports

Travere Therapeutics (TVTX) Income Statement

596 Followers

Travere Therapeutics Income Statement

Last quarter (Q4 2025), Travere Therapeutics's total revenue was $129.69M, an increase of 73.41% from the same quarter last year. In Q4, Travere Therapeutics's net income was $-21.99M. See Travere Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 490.73M$ 233.18M$ 145.24M$ 109.46M$ 131.84M
Gross Profit
$ 419.65M$ 225.43M$ 133.79M$ 105.04M$ 128.02M
Operating Expenses
$ 482.47M$ 549.26M$ 521.93M$ 424.85M$ 327.44M
Depreciation and Amortization
$ 60.74M$ 43.55M$ 38.53M$ 20.72M$ 12.75M
EBITDA
$ 22.22M$ -265.77M$ -326.25M$ -299.42M$ -184.46M
Operating Income
$ -62.82M$ -323.83M$ -388.14M$ -319.81M$ -199.43M
Other Income/Expenses
$ 13.55M$ 3.32M$ 12.03M$ -11.34M$ -17.46M
Pretax Income
$ -49.27M$ -320.51M$ -376.11M$ -331.15M$ -216.88M
Net Income
$ -50.26M$ -321.55M$ -111.40M$ -278.48M$ -180.09M
Per Share Metrics
Basic EPS
$ -0.56$ -4.08$ -1.50$ -4.37$ -3.01
Diluted EPS
$ -0.56$ -4.08$ -1.50$ -4.37$ -3.01
Weighted Average Shares Outstanding
 89.21M 78.89M 74.27M 63.76M 59.83M
Weighted Average Shares Outstanding (Diluted)
 89.21M 78.89M 74.27M 63.76M 59.83M
Currency in USD

Travere Therapeutics Earnings and Revenue History